Advanced cervix cancer patient with chemotherapy-induced grade IV myelosuppression achieved complete remission with cadonilimab: A case report

Figure 1 Computed tomography scans of the lungs were obtained before and after treatment with cadonilimab. A: Computed tomography (CT) image of the chest on July 8, 2022, after grade 4 myelosuppression induced by chemotherapy; B: CT image of the chest on August 27, 2022, after three doses of cadonilimab; C: CT image of the chest on October 28, 2022, after treatment with cadonilimab; D: CT image of the chest on January 18, 2023, after treatment with cadonilimab; E: CT image of the chest on April 27, 2023, indicating complete remission (CR); F: CT image of the chest on July 24, 2023, showing that the patient achieved sustained CR.